PROCESS FOR SYNTHESIS OF DIARYLPRIMIDINE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR

A method for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor such as etravirine is provided Typically, etravirine is synthesized by the steps of a Condensing 2,4,6-trichlorpyrimidine with 3,5-dimethyl-4-hydroxybenzonitrile to obtain compound (V), b Condensing compound (V...

Full description

Saved in:
Bibliographic Details
Main Authors JOSHI SHASHIKANT GANGARAM, MAIKAP GOLAKCHANDRA SUDARSHAN, MEHTA SAMIT SATISH, PARDESHI DEVISING RAMESHSING, KAMBLE MANGESH GORAKHANATH, GURJAR MUKUND KESHAV
Format Patent
LanguageEnglish
Published 30.01.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A method for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor such as etravirine is provided Typically, etravirine is synthesized by the steps of a Condensing 2,4,6-trichlorpyrimidine with 3,5-dimethyl-4-hydroxybenzonitrile to obtain compound (V), b Condensing compound (V) with 4-aminobenzonitrile to obtain compound (VI), c Ammonolysis of compound (VI) to get compound (IV), d Halogenation of compound (IV) to get etravirine.
Bibliography:Application Number: ZA20110008690